Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy

PHILADELPHIA — The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania announces the launching of a first-of-its-kind interdisciplinary center focused on discovering novel treatments for orphan diseases. The Center will bring together, without institutional walls, all necessary approaches to attacking and treating orphan diseases: establishing dedicated research support facilities, translating findings into therapies, fostering targeted grant awards, and educating physicians and researchers.

Formation of the new Penn Center for Orphan Disease Research and Therapy was catalyzed by a $10 million gift from an anonymous donor, whose vision matched that of Penn Medicine in developing treatments for these diseases. The Center will fill a crucial need by providing the core laboratories, techniques, collaborative relationships, and expertise to lead an international, coordinated effort in the eradication of orphan diseases. Key among these resources is a state-of-the-art, robotically controlled drug screening laboratory that enables researchers from around the world to rapidly probe existing compound libraries for effective, orphan disease treatments.

Diseases are classified as orphan when they affect fewer than 200,000 people. However, as there are approximately 7,000 diseases now identified in this population, more than 25 million Americans are currently afflicted. Many of these diseases are caused by genetic mutations and are diagnosed in children. Research in many orphan diseases has lagged behind other major disease categories, such as diabetes and cardiovascular disease, in part because of a relative lack of technical expertise and funding mechanisms. Penn's Center will specifically address these needs.

"The research and development marketplace is not designed to optimally support research to develop the therapies so desperately needed for orphan diseases," explains Glen N. Gaulton, Ph.D., Executive Vice Dean and Chief Scientific Officer at the Perelman School. "Penn's new Center for Orphan Disease Research and Therapy will build not only strong collaborative relationships throughout Penn, but also with other leading academic medical centers, as well as public and private institutions—all designed to translate innovative research into the clinic. There's simply nothing else like it."

"This is a wonderful example of philanthropy in action," says J. Larry Jameson, M.D., Ph.D., Executive Vice President for the Health System and Dean of the Perelman School of Medicine. "The Center will be a natural extension of Penn's expertise in orphan diseases, and this strategic investment will galvanize support for orphan disease research around the globe. I am proud that Penn Medicine is taking a clear leadership position in transforming the health of millions."

Jameson adds that he is delighted that his predecessor, former Perelman School Dean Arthur H. Rubenstein, MBBCh, has agreed to serve as special advisor to the Center during the first several months, which will include overseeing the search for the Center's first Director.

The Center will be a nexus for connecting:

  • Researchers and clinicians at Penn with other public and private institutions to work on projects aimed at finding and testing treatments for orphan diseases;
  • Approaches to treatment that are common among various orphan diseases;
  • Researchers with organizations that fund biomedical research for orphan diseases; and
  • Investigators within small and large pharmaceutical firms to develop and test treatments for orphan diseases.

Working together with other academic institutions, the National Institutes of Health, Pharma, and private philanthropy, the Center aims to reduce dramatically the technological and financial burden of investigators working in isolation by supporting a range of collaborative approaches:

  • Robotics for large-scale drug screening,
  • Biospecimen repositories to store samples,
  • Genotyping and bioinformatics services to identify causative genes,
  • Cell-based systems for developing new tests,
  • Nano-scale systems for developing new ways to deliver drugs, and
  • Small and large animal models for testing potential treatments.


The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.


Other Research News

Default Image
Sep 03, 2013

Online now: September 2013 issue ASBMB Today

Sept. 3, 2013 — The cover story in the September issue of ASBMB Today is about investigators who… read more
Prevalence of TP53 mutation by diagnostic group.
Jun 10, 2013

How Can We Screen for Pancreatic Cancer and its Precursors?

Individuals with invasive pancreatic cancer or high-grade dysplasia can be identified based on a… read more
Mullins teaches emergency medicine in Bolivia​
Feb 25, 2013

Mullins teaches emergency medicine in Bolivia​

Flying into El Alto International Airport in Bolivia in winter is breathtaking, both literally and… read more
Default Image
Jan 14, 2011

Genetic Risk Factors Identified for Coronary Artery Disease and Heart Attack

(PHILADELPHIA) – Coronary artery disease (CAD) is the single largest cause of death in adults in… read more
U of G Faculty Receive $1.6 Million in SSHRC Grants
Sep 17, 2013

U of G Faculty Receive $1.6 Million in SSHRC Grants

September 17, 2013 - News Release Research in the arts, humanities and social sciences at Guelph… read more
Default Image
Mar 10, 2011


Date: March 10, 2011 UC San Diego Launches Nation’s First Non-Supplement Study on Prostate… read more
A Havasupai basket, from 1907
Aug 08, 2013

HeLa, the Havasupai, and Informed Consent

VN:F [1.9.22_1171] A Havasupai basket, from 1907 HeLa cells are back in the news, with a Comment… read more
Adrianne Haggins, M.D., M.S.
Oct 17, 2013

Will health insurance expansion cut ER use? U-M study in teens and young adults may help predict

ANN ARBOR, Mich. — As the nation’s health care system prepares for uninsured Americans to gain… read more
Default Image
May 31, 2013

Weighing In On The Obesity Bias

For immediate release:May 31, 2013 WEIGHING IN ON THE OBESITY BIASFitness Professionals’ Role in… read more
Susan Desmond-Hellmann, MD, MPH
Mar 07, 2013

UCSF Chancellor Named to Facebook Board of Directors

UC San Francisco Chancellor Susan Desmond-Hellmann, MD, MPH, is joining Facebook’s board of… read more best odds.

Look revie here - Online betting full information by
Reviw on bokmaker Number 1 in uk William Hill
Full Reviw on best bokmaker - Ladbrokes full information